Tag: <span>Betty Pang</span>

North America Legal Chronicle. September 27, 2023

Boston Scientific’s $850 Million Acquisition of Relievant MedSystems

By Pietro Martinoia

Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. September 26, 2023

Neumora Therapeutics’ $250.1 Million Initial Public Offering

By Pietro Martinoia

Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. September 22, 2023

Gilead’s $2 Billion Senior Unsecured Notes Offering

By Pietro Martinoia

Davis Polk advised Gilead, and Latham & Watkins advised the underwriters. Gilead Sciences, Inc. (Nasdaq: GILD) announced the pricing of senior unsecured notes in an aggregate...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. September 12, 2023

Thoma Bravo’s Acquisition of NextGen Healthcare

By Laura Testa

Latham & Watkins advised NextGen Healthcare, Goodwin Procter advised Thoma Bravo, and Skadden advised Morgan Stanley & Co. LLC as financial advisor to NextGen Healthcare on...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 29, 2023

VBA’s US$156 Million Growth Funding From Spectrum Equity

By Marco Zingaro

Latham & Watkins advises Spectrum Equity in US$156 million growth funding for VBA. VBA, a leader in cloud-based benefits software for healthcare payers, has announced that...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 28, 2023

Heron Therapeutics’ Capital Credit Facility Agreement With Hercules Capital

By Marco Zingaro

Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 28, 2023

MindMed’s Senior Secured Credit Facility With K2 HealthVentures LLC

By Marco Zingaro

Latham & Watkins advises MindMed in growth financing with K2 HealthVentures. Mind Medicine Inc. (MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 26, 2023

Ikena Oncology’s Acquisition of Pionyr Immunotherapeutics

By Pietro Martinoia

Latham & Watkins advised Pionyr on the sale. Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena) and Pionyr Immunotherapeutics, Inc. have announced the closing of Ikena’s acquisition of...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 24, 2023

Revolution Medicines’ Acquisition of EQRx

By Pietro Martinoia

Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 24, 2023

PROCEPT BioRobotics’ $172.5 Million Common Stock Offering

By Pietro Martinoia

Latham & Watkins advised PROCEPT BioRobotics, and Shearman & Sterling advised the underwriters. PROCEPT BioRobotics Corporation announced a follow-on offering of 5,085,494 shares of common stock at...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. July 26, 2023

Korro Bio and Frequency Therapeutics’ Merger Agreement

By Pietro Martinoia

Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. June 24, 2023

RadNet’s $259.2 Million Common Stock Public Offering

By Pietro Martinoia

Sheppard Mullin represented RadNet, and Latham & Watkins represented the underwriters. RadNet, Inc. (NASDAQ: RDNT) has announced the closing of its underwritten public offering of 8,711,250 shares...

This content is for Standard 1 Year members only.
Login Join Now

Virgin Pulse and HealthComp’s $3 Billion Merger

iSpot’s Acquisition of 605

ISG Enterprises’ Acquisition of Sunnyside

Gringo’s BRL150 Million Investment Round

Aqua Capital’s Acquisition of Exata Holding

Saipem’s Sale and Purchase Agreement

AMEA Power’s First Solar IPP Project in El Metbassta (Tunisia)

Puma Private Equity’s £3.5 Million Investment in TravelLocal

Infracapital’s €407 Million Acquisition of Vopak Rotterdam Botlek

Eskom’s Closing of Oya and Umoyilanga Energy Deals

Post For Investment’s Acquisition of Roaderz Technologies

YANMU Logistics Park’s Financing Agreement with CIB

Panaxia Labs Israel’s Share Swap Agreement with the Barak Group

Menora Mivtachim’s Public Offering

International Schools Partnership’s Acquisition of The English College

Northland Power and Mitsui & Co’s Financing of 1,022MW Hai Long Offshore Wind Farm

LVGEM Real Estate’s Issuance of Guaranteed Commercial Paper Notes

Mongolian Mining’s Exchange Offer

Osborne Clarke Opens New Office in Miami with Javier Fernández-Samaniego

We will have to wait until October 13th to know the result of the vote on the Allen & Overy Shearman Sterling merger

Armstrong Teasdale Adds Intellectual Property Lawyer Douglas Scholer

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

Osborne Clarke Opens New Office in Miami with Javier Fernández-Samaniego

Armstrong Teasdale Adds Intellectual Property Lawyer Douglas Scholer

Cains adds Paul Freeman to litigation practice

Betty Pang

Boston Scientific’s $850 Million Acquisition of Relievant MedSystems

Neumora Therapeutics’ $250.1 Million Initial Public Offering

Gilead’s $2 Billion Senior Unsecured Notes Offering

Thoma Bravo’s Acquisition of NextGen Healthcare

VBA’s US$156 Million Growth Funding From Spectrum Equity

Heron Therapeutics’ Capital Credit Facility Agreement With Hercules Capital

MindMed’s Senior Secured Credit Facility With K2 HealthVentures LLC

Ikena Oncology’s Acquisition of Pionyr Immunotherapeutics

Revolution Medicines’ Acquisition of EQRx

PROCEPT BioRobotics’ $172.5 Million Common Stock Offering

Korro Bio and Frequency Therapeutics’ Merger Agreement

RadNet’s $259.2 Million Common Stock Public Offering